Finding a lump in his neck, Jim Reynolds began a journey of fighting an HPV-related cancer that led him to Bryan Bell, M.D., a head and neck cancer surgeon with Providence Cancer Institute. In this KPTV Health Watch news story, learn about Jim's treatment and how the human papilloma virus vaccine can help prevent cancer.
Other content in this Stream
Please revert to normal e-prescribing workflows and stop using paper prescriptions.
Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.
The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic).
Supporting thousands of patients experiencing food insecurity, a converted space at Providence Gateway Internal Medicine clinic is filled with fresh fruits and vegetables, meat, milk, eggs and more.
Jamie Zilverberg, MSN, FNP, AOCNP, receives the prestigious 2024 Values in Action Award, the highest honor given at Providence St. Joseph Health.
In honor of International Day of Women and Girls in Science we highlight a researcher at Earle A. Chiles Research Institute, the research arm of Providence Cancer Institute.
Providence registered dietitian Christina Speaks, MS, RDN, LD, shares valuable information about food and common cancer myths.
New study evaluates immunotherapy in combination with other medications in people with endometrial cancer, and a phase I trial for people with AML assesses a non-engineered natural killer cell therapy
Providence and Regence have reached an agreement to continue care delivery services together.
"Within Reach: The Fight to Finish Cancer" follows patient participants and teams of researchers and clinicians at Providence Cancer Institute working to create a living drug for incurable cancers.
New articles co-authored by Dr. Rachel Sanborn feature amivantamab studies for people with NSCLC.
The Oregon Health Authority has selected the Portland, Oregon-based Center for Outcomes Research & Education (CORE) to create an evaluation design for Oregon's 2022-2027 1115 Medicaid waiver.
Highlights from 2023 events, achievements and advancements at Providence Cancer Institute.
Providence hematology oncologist and outdoors enthusiast Eric C. Anderson, M.D., shares his love of the Pacific Northwest and his philosophy of care for patients.
A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.
Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.
SITC 2023 provides a glimpse into scientific advances and breakthroughs in cancer immunotherapy by researchers from around the world.
Providence Cancer Institute lung cancer expert to present a virtual education talk on lung cancer screening, prevention and latest treatments.
It took a total team effort to make a hospice patient’s dream come true of touching a horse before she died.
Two new studies available at Earle A. Chiles Research Institute, at division of Providence Cancer Institute of Oregon, to evaluate new treatments for triple-negative breast cancer.